DK1583525T3 - Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdomme - Google Patents

Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdomme

Info

Publication number
DK1583525T3
DK1583525T3 DK03815354.0T DK03815354T DK1583525T3 DK 1583525 T3 DK1583525 T3 DK 1583525T3 DK 03815354 T DK03815354 T DK 03815354T DK 1583525 T3 DK1583525 T3 DK 1583525T3
Authority
DK
Denmark
Prior art keywords
skin
phototherapy
salicylates
antioxidants
treatment
Prior art date
Application number
DK03815354.0T
Other languages
English (en)
Inventor
Gerhard Saalmann
Peter Saalmann
Hagen Tronnier
Original Assignee
Medlight Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medlight Gmbh filed Critical Medlight Gmbh
Application granted granted Critical
Publication of DK1583525T3 publication Critical patent/DK1583525T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03815354.0T 2003-01-17 2003-12-23 Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdomme DK1583525T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10301917A DE10301917B4 (de) 2003-01-17 2003-01-17 Verwendung von Substanzen der Porphyrinsynthese bei der Phototherapie von Haut- oder Gelenkerkrankungen des Menschen oder von Säugetieren
PCT/DE2003/004254 WO2004064827A1 (de) 2003-01-17 2003-12-23 Verwendung von substanzen der porphyrinsynthese für die anwendung in der phototherapie sowie zur behandlung von haut- und/oder gelenkerkrankungen

Publications (1)

Publication Number Publication Date
DK1583525T3 true DK1583525T3 (da) 2011-01-03

Family

ID=32602752

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03815354.0T DK1583525T3 (da) 2003-01-17 2003-12-23 Anvendelse af porphyrinsyntesesubstanser i kombination med salicylater og antioxdanter til anvendelse i fototerapi til behandling af hud- og/eller ledsygdomme

Country Status (13)

Country Link
US (1) US20070099878A1 (da)
EP (1) EP1583525B1 (da)
JP (1) JP2006514072A (da)
AT (1) ATE479431T1 (da)
AU (1) AU2003300499A1 (da)
CY (1) CY1110957T1 (da)
DE (2) DE10301917B4 (da)
DK (1) DK1583525T3 (da)
ES (1) ES2351971T3 (da)
PT (1) PT1583525E (da)
RU (1) RU2336078C2 (da)
SI (1) SI1583525T1 (da)
WO (1) WO2004064827A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
DE102011117364A1 (de) * 2011-10-29 2013-05-02 Merck Patent Gmbh Hautaufheller in der Phototherapie
DE202013003573U1 (de) 2013-04-16 2013-06-04 Gerhard Saalmann Ganzkörper-Belichtungseinheit
RU2712806C1 (ru) * 2019-05-20 2020-01-31 Федеральное государственное бюджетное учреждение "Государственный научный центр лазерной медицины имени О.К. Скобелкина Федерального медико-биологического агентства" Способ лечения больных перипротезной инфекцией после эндопротезирования сустава

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
DE4320871C2 (de) * 1993-06-24 1995-05-04 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an delta-Aminolävulinsäure
WO1996006602A1 (en) 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
DE4440112A1 (de) * 1994-11-11 1996-05-15 Jan H Dr Wilkens Bestrahlungsanordnung zur Behandlung von Hauterkrankungen
US5530157A (en) * 1995-02-16 1996-06-25 Scios Nova Inc. Anti-inflammatory benzoic acid derivatives
AU708076B2 (en) * 1995-03-10 1999-07-29 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
EP0959879B1 (en) * 1996-10-10 2004-05-06 The General Hospital Corporation Photodynamic therapy for the treatment of osteoarthritis
AU4645099A (en) * 1998-07-09 2000-02-01 Yoram Harth Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea
DE19852245A1 (de) * 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Nanoemulsion
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
WO2002019972A2 (en) * 2000-09-08 2002-03-14 Vivier Canada Inc. Stabilized ascorbic acid solutions
DE10063076A1 (de) 2000-12-18 2002-06-27 Medac Klinische Spezialpraep Verwendung von 5-Aminolävulinsäure zur Restenose-Prophylaxe
US20030082101A1 (en) * 2001-06-11 2003-05-01 Cavalier Discovery Accelerators for increasing the rate of formation of free radicals and reactive oxygen species
US6723750B2 (en) * 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders

Also Published As

Publication number Publication date
DE10301917A1 (de) 2004-07-29
EP1583525B1 (de) 2010-09-01
RU2005127035A (ru) 2006-01-27
EP1583525A1 (de) 2005-10-12
SI1583525T1 (sl) 2011-01-31
CY1110957T1 (el) 2015-06-11
PT1583525E (pt) 2010-12-07
ATE479431T1 (de) 2010-09-15
US20070099878A1 (en) 2007-05-03
DE10301917B4 (de) 2007-02-01
AU2003300499A1 (en) 2004-08-13
ES2351971T3 (es) 2011-02-14
RU2336078C2 (ru) 2008-10-20
DE50313052D1 (de) 2010-10-14
WO2004064827A1 (de) 2004-08-05
JP2006514072A (ja) 2006-04-27

Similar Documents

Publication Publication Date Title
CY1115524T1 (el) Ανθρωπινα μονοκλωνικα αντισωματα εναντι της ανθρωπινης il-4
DK1814590T4 (da) Behandling af obesitet og beslægtede sygdomme.
CY2017013I1 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
EP1648385A4 (en) SYSTEM AND METHOD FOR THE PHOTODYNAMIC TREATMENT OF COMBUSTIONS, WOUNDS AND RELATED SKIN DISEASES
GB2444855B8 (en) Apparatus and method for photodynamic diagnosis and therapy of skin diseases and light source systemthereof
DK1742644T3 (da) Terapeutisk sammensætning indeholdende mindst et pyrrolbenzodiazepin-derivat og fludarabin
ATE461217T1 (de) Glp-1-verbindungen
BR112012010027A2 (pt) dispositivo para uso pessoal em uma fototerapia
CL2008001932A1 (es) Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer.
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
ATE380548T1 (de) Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie
AR007145A1 (es) Metodo y cateter globo para fototerapia de medios columnares
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
IS7348A (is) N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
CY1111656T1 (el) Παραγωγα αλφα-αμινοαμιδιου χρησιμα εις την θεραπευτικη αγωγη εθιστικων παθησεων
DK1660041T3 (da) Ikke-polær fotosensibilisator til fotodynamisk terapi
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
CY1115407T1 (el) Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων
DE602004023183D1 (de) Gegen antikörper gerichtete photodynamische therapie
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
WO2007100839A3 (en) Method and apparatus for application of light to tissue
ATE511401T1 (de) Kombinierte gentherapie zur behandlung makroskopischer glioma
BR0313611A (pt) Uso da combinação de ciclesonida e anti-histaminas para o tratamento de rinite alérgica
CY1110957T1 (el) Χρηση ουσιων της συνθεσης πορφυρινης σε συνδυασμο με σαλικυλικα και αντιοξειδωτικα για την εφαρμογη στην φωτοθεραπεια για την αγωγη δερματικων ασθενειων και/ή ασθενειων των αρθρωσεων
WO2006047414A3 (en) Chemiluminescent phototherapy device